10:09 EDT BioXcel Therapeutics (BTAI) trading halted, volatility trading pause
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTAI:
- BioXcel Therapeutics reports Q2 EPS ($2.45), consensus ($1.56)
- BioXcel Therapeutics Raises $30.4M, Meets Financing Covenant
- BioXcel’s BXCL501 Study: A Potential Game-Changer for Psychomotor Agitation Treatment
- BioXcel Highlights BXCL501’s Market Potential for Agitation
- BTAI Earnings this Week: How Will it Perform?